Please ensure Javascript is enabled for purposes of website accessibility

Dentsply Sirona Ups Its Full-Year Outlook After Beating Q2 Earnings Estimates

By Keith Speights - Aug 2, 2019 at 3:00PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The dental solutions provider didn't meet analysts' revenue expectations in Q2 but achieved significant bottom-line improvement.

Dentsply Sirona (XRAY 1.98%) has been on a roll so far in 2019. Its stock was up 46% by the end of July. The company also announced first-quarter results in May with solid adjusted earnings per share (EPS) growth.

Investors hoped Dentsply Sirona's roll would continue when the company announced its second-quarter results before the market opened on Friday. Here are the highlights from the dental solutions provider's Q2 update.

Man holding a large tooth model in one hand and a pile of coins in the other hand

Image source: Getty Images.

By the numbers

Dentsply Sirona reported that its revenue in the second quarter declined 3.1% from the prior-year period to $1.01 billion. This number came in a little below the consensus Wall Street analysts' revenue estimate of $1.04 billion. 

Under generally accepted accounting principles (GAAP), Dentsply's net income in the second quarter was $36.4 million, or $0.16 per share. This reflected a big improvement from the prior-year period GAAP net loss of $1.12 billion, or $4.98 per share.

The company announced adjusted earnings per share of $0.66 in the second quarter, marking a 10% year-over-year increase. It also beat the average analysts' adjusted EPS estimate of $0.63 per share.

Behind the numbers

That year-over-year revenue decrease wasn't quite as bad as it looks at first glance. Adjusting for foreign exchange fluctuations, acquisitions, and discontinued products, Dentsply Sirona generated 3% year-over-year revenue growth. The company refers to this as its "internal sales growth" rate. CEO Don Casey said that this 3% internal sales growth was in line with the target the company provided in November 2018.

Using this internal sales growth rate is helpful in examining how the company performed in different geographic regions. Dentsply Sirona reported that U.S. revenue fell by 2.6% but by only 1.5% on an internal basis. The difference was more pronounced in other regions. The company's European region revenues declined 1.1% year over year on a reported basis but increased by 7.1% on an internal sales growth basis. Dentsply's "rest of world" region revenue dropped 6.9% on a reported basis but rose 2.4% on an internal basis.

The huge improvement in GAAP net income stemmed primarily from a $1.09 billion goodwill impairment recorded in the second quarter of 2018. However, Dentsply Sirona also announced slightly lower selling, general, and administrative expenses in Q2 than it did in the prior-year period. In addition, the company's restructuring costs in the second quarter were much lower than a year ago.

Looking ahead

Dentsply boosted its guidance for full-year 2019. The company now expects adjusted EPS to be between $2.35 and $2.45, up from the previous outlook of $2.30 to $2.40. It also continues to anticipate revenue will be in a range between $3.95 billion and $4.05 billion.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

DENTSPLY SIRONA Inc. Stock Quote
DENTSPLY SIRONA Inc.
XRAY
$39.72 (1.98%) $0.77

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
344%
 
S&P 500 Returns
120%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.